These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 33632299)
1. Chromatin remodeling by the histone methyltransferase EZH2 drives lung pre-malignancy and is a target for cancer prevention. Tellez CS; Picchi MA; Juri D; Do K; Desai DH; Amin SG; Hutt JA; Filipczak PT; Belinsky SA Clin Epigenetics; 2021 Feb; 13(1):44. PubMed ID: 33632299 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells. Kikuchi J; Takashina T; Kinoshita I; Kikuchi E; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Marquez VE; Nishimura M; Dosaka-Akita H Lung Cancer; 2012 Nov; 78(2):138-43. PubMed ID: 22925699 [TBL] [Abstract][Full Text] [Related]
3. Interplay between EZH2 and G9a Regulates CXCL10 Gene Repression in Idiopathic Pulmonary Fibrosis. Coward WR; Brand OJ; Pasini A; Jenkins G; Knox AJ; Pang L Am J Respir Cell Mol Biol; 2018 Apr; 58(4):449-460. PubMed ID: 29053336 [TBL] [Abstract][Full Text] [Related]
4. DZNep, inhibitor of S-adenosylhomocysteine hydrolase, down-regulates expression of SETDB1 H3K9me3 HMTase in human lung cancer cells. Lee JK; Kim KC Biochem Biophys Res Commun; 2013 Sep; 438(4):647-52. PubMed ID: 23933322 [TBL] [Abstract][Full Text] [Related]
5. A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis. Coward WR; Feghali-Bostwick CA; Jenkins G; Knox AJ; Pang L FASEB J; 2014 Jul; 28(7):3183-96. PubMed ID: 24652950 [TBL] [Abstract][Full Text] [Related]
6. Involvement of EZH2, SUV39H1, G9a and associated molecules in pathogenesis of urethane induced mouse lung tumors: potential targets for cancer control. Pandey M; Sahay S; Tiwari P; Upadhyay DS; Sultana S; Gupta KP Toxicol Appl Pharmacol; 2014 Oct; 280(2):296-304. PubMed ID: 25168426 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of EZH2 (Enhancer of Zeste Homolog 2) Attenuates Neuroinflammation via H3k27me3/SOCS3/TRAF6/NF-κB (Trimethylation of Histone 3 Lysine 27/Suppressor of Cytokine Signaling 3/Tumor Necrosis Factor Receptor Family 6/Nuclear Factor-κB) in a Rat Model of Subarachnoid Hemorrhage. Luo Y; Fang Y; Kang R; Lenahan C; Gamdzyk M; Zhang Z; Okada T; Tang J; Chen S; Zhang JH Stroke; 2020 Nov; 51(11):3320-3331. PubMed ID: 32933418 [TBL] [Abstract][Full Text] [Related]
8. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Fiskus W; Wang Y; Sreekumar A; Buckley KM; Shi H; Jillella A; Ustun C; Rao R; Fernandez P; Chen J; Balusu R; Koul S; Atadja P; Marquez VE; Bhalla KN Blood; 2009 Sep; 114(13):2733-43. PubMed ID: 19638619 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells. Nakagawa S; Sakamoto Y; Okabe H; Hayashi H; Hashimoto D; Yokoyama N; Tokunaga R; Sakamoto K; Kuroki H; Mima K; Beppu T; Baba H Oncol Rep; 2014 Feb; 31(2):983-8. PubMed ID: 24337160 [TBL] [Abstract][Full Text] [Related]
10. Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity. Bate-Eya LT; Gierman HJ; Ebus ME; Koster J; Caron HN; Versteeg R; Dolman MEM; Molenaar JJ Eur J Cancer; 2017 Apr; 75():63-72. PubMed ID: 28214660 [TBL] [Abstract][Full Text] [Related]
11. EZH2: a novel target for cancer treatment. Duan R; Du W; Guo W J Hematol Oncol; 2020 Jul; 13(1):104. PubMed ID: 32723346 [TBL] [Abstract][Full Text] [Related]
12. Selective targeting of histone modification fails to prevent graft versus host disease after hematopoietic cell transplantation. Alahmari B; Cooper M; Ziga E; Ritchey J; DiPersio JF; Choi J PLoS One; 2018; 13(11):e0207609. PubMed ID: 30452487 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of microRNA-218 via EZH2-mediated H3K27 trimethylation is involved in malignant transformation of HBE cells induced by cigarette smoke extract. Wang B; Liu Y; Luo F; Xu Y; Qin Y; Lu X; Xu W; Shi L; Liu Q; Xiang Q Arch Toxicol; 2016 Feb; 90(2):449-61. PubMed ID: 25526925 [TBL] [Abstract][Full Text] [Related]
14. G9a regulates tumorigenicity and stemness through genome-wide DNA methylation reprogramming in non-small cell lung cancer. Pangeni RP; Yang L; Zhang K; Wang J; Li W; Guo C; Yun X; Sun T; Wang J; Raz DJ Clin Epigenetics; 2020 Jun; 12(1):88. PubMed ID: 32552834 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of the histone methyltransferase EZH2 contributes to the epigenetic programming of decidualizing human endometrial stromal cells. Grimaldi G; Christian M; Steel JH; Henriet P; Poutanen M; Brosens JJ Mol Endocrinol; 2011 Nov; 25(11):1892-903. PubMed ID: 21903722 [TBL] [Abstract][Full Text] [Related]
16. Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in Colorectal Carcinoma Cells. Jacksi M; Schad E; Tantos A Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672463 [TBL] [Abstract][Full Text] [Related]
17. EZH2 as a major histone methyltransferase in PDGF-BB-activated orbital fibroblast in the pathogenesis of Graves' ophthalmopathy. Visamol S; Palaga T; Saonanon P; Pruksakorn V; Hirankarn N; van Hagen PM; Dik WA; Virakul S Sci Rep; 2024 Apr; 14(1):7947. PubMed ID: 38575707 [TBL] [Abstract][Full Text] [Related]
18. Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells. Takashina T; Kinoshita I; Kikuchi J; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Nishimura M; Dosaka-Akita H Cancer Sci; 2016 Jul; 107(7):955-62. PubMed ID: 27116120 [TBL] [Abstract][Full Text] [Related]
19. 3-deazaneplanocin A, a histone methyltransferase inhibitor, improved the chemoresistance induced under hypoxia in melanoma cells. Hosokawa M; Tetsumoto S; Yasui M; Kono Y; Ogawara KI Biochem Biophys Res Commun; 2023 Oct; 677():26-30. PubMed ID: 37542772 [TBL] [Abstract][Full Text] [Related]
20. 3-Deazaneplanocin A (DZNep), an inhibitor of the histone methyltransferase EZH2, induces apoptosis and reduces cell migration in chondrosarcoma cells. Girard N; Bazille C; Lhuissier E; Benateau H; Llombart-Bosch A; Boumediene K; Bauge C PLoS One; 2014; 9(5):e98176. PubMed ID: 24852755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]